We therefore hypothesized that megakaryocyte progenitors in subsets of MDS patients with thrombocytopenia would elevate expression levels of mitotic genes, including AURKA, AURKB, and PLK1, which in turn would promote cytokinesis/cell cycling rather than endomitosis. The gene discussed is PLK1; the disease is myelodysplastic syndrome.